Altria shares are on pace for their highest close in over six years after the company lifted its profit outlook and said ...

Q2 2025 Management View Steven O. Vondran, President and CEO, stated that "2025 continues to be a good year." He highlighted ...

Join Jeff Margolin of First Trust on CEF Insights for a 2025 midyear review of closed-end fund (CEF) performance and expert ...

Shipowners grapple with OPEC+ supply increases, tensions in the Middle East, and rising numbers of newbuildings.

The International Monetary Fund raised its outlook for economic growth across emerging market and developing economies this ...

Novo Nordisk lowers 2025 guidance as Wegovy and Ozempic face slower U.S. uptake, competition, and continued compounded GLP-1 ...

Johnson Controls International (JCI) reports strong Q3 with sales of $6.05B, up 2.6% YoY, exceeding analyst estimates. Gross profit also rose, leading to an upward revision of fiscal 2025 earnings ...

Novo Nordisk's stock has dropped 21% after the company lowered its sales forecast and named Mike Doustdar as the new CEO.

The International Monetary Fund on Tuesday raised its global growth forecasts for 2025 and 2026 slightly, citing ...

Analysts William Tng and Tan Jie Hui believe Venture’s shares could find “support” at their FY2025 book value per share ...

Despite maintaining a target of $3.5 billion in 2025 cost savings, UPS noted attrition linked to the Amazon volume wind-down ...

American Tower (AMT) stock dipped 2.3% in Tuesday premarket trading after REIT's 2025 AFFO guidance midpoint was ...